Ancient grains show promise for type 2 diabetes

A meta-analysis in the journal Nutrition, Metabolism and Cardiovascular Diseases finds that ancient grains like oats, brown rice, and millet may improve lipid profiles in type 2 diabetes patients, but variations in study designs call for further research to confirm these benefits.

Understanding the 3D Shape of the Genome Reveals Future Cancer Drug Targets

Computer artwork representing brain cancer, with a cancer cell between two halves of a human brain. Researchers at Sanford Burnham Prebys have published new findings

April 30, 2023

HU-6 by Rivus Pharmaceuticals for Hypertriglyceridemia: Likelihood of Approval

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

April 20, 2024

Could billions of dollars in AI funding lead to the same number of new drugs?

Drug discovery has quickly become the most enticing place to apply artificial intelligence. Billions of dollars are being invested in AI-driven “techbios.” In an industry

June 25, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.